2022 Top News from Drug Topics
Take a look back at the top 15 articles that we published in 2022.
New Approaches in Psoriasis and Psoriatic Arthritis Treatment
Understanding the relationship between psoriasis and psoriatic arthritis can help.
Treating Skin Cancers in the Immunotherapy Era
Examining what immunotherapy can do for skin cancer treatment.
What’s New in Acne and Rosacea?
Valerie D. Callender, MD, FAAD, offers a look at the newest treatments available for acne and rosacea.
A Study of Immune Checkpoint Inhibitors and Complication Rates
Immune checkpoint inhibitor therapy does not appear to increase complication rates in patients undergoing dermatologic procedures.
Evaluating Chronic Itch and Quality of Life
Several factors predict itch-specific quality of life in patients with chronic itch.
Biosimilar Uptake Increases After Changes to EHR
Biosimilar medications stand to significantly increase cost savings for patients.
Mental Health Status and Access to Services Are Key Issues for LGBTQ+ Patients
When dealing with marginalized and underserved populations, it is important to understand barriers to care and why they exist.
Mental Health Telemedicine Barriers Spur Call for Reform
With increasing use of telehealth, patients need access to resources that let them get the most out of the experience.
How Drug Shortages Are Prevented by the FDA
With supply chain issues impacting many industries, drug shortages have occurred. How does the FDA address them?
Opioid Use in Psoriatic Arthritis Is Associated With Higher Health Care Costs, Utilization
New pathways of care are needed to improve health care spending.
Suggestions for Saving: Help Patients Navigate Diabetes Management Costs
By offering resources such as free samples and generic alternatives, pharmacists can help patients lower costs.
Study Sees Link Between Smartphone Screen Time, Symptoms of Mental Illness
Social support and education may be the solution.
Digital Therapeutics for Asthma Control May Change Treatment Paradigm
Study participants experienced better outcomes vs standard of care with a digital inhaler system.
Relyvrio: A New FDA-Approved Treatment for Patients With ALS
Relyvrio is intended to slow the disease progression of amyotrophic lateral sclerosis.
What’s in a Title?
When it comes to practicing pharmacy, do titles and degrees actually matter?
Technology Tools for Mental Health Screening
Online portals are accessible via tablet or computer and can streamline the mental health screening process.
Examining the Impact of the Roe v Wade Decision on Medication Access
Investigators set out to evaluate how medication access for certain rheumatic conditions has changed since June 2022.
Time To First Prescription Fill at Health System, External Pharmacies Reviewed
Timing of treatment initiation is crucial for patients with cancer.
Using Data to Improve Health Equity
Thinking carefully about how data are collected is the first step improving health outcomes.
Improving Vaccine Uptake Requires More Than a ‘One Size Fits All’ Approach
Addressing hesitancy is more than just offering pertinent information.
Tips for Tackling PBM Audits—Together
Working collaboratively can be key to either avoiding a PBM audit altogether or making the process as painless as possible.
Vaccine Candidates Show Promise for Pediatric RSV
Results of multiple studies were presented at IDWeek 2022.
Spotlight on Pediatric COVID-19 Vaccines
After multiple approvals and emergency use authorizations, It’s time to take stock of the state of pediatric COVID-19 vaccines.
